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patients regarding their response to treatment. 6 The issue of variable responses raises the question, For which patients is day treatment suitable? To answer this question, it is important to identify the types of patients who respond particularly well (or poorly) to day treatment. A search for predictors of outcome is one way to get closer to clarifying the issue of differential indication for day treatment. However, as Chiesa and Fonagy 7 point out, only a handful of studies have attempted to identify patient characteristics that are prognostic of outcome of treatments for PD in general. Few have addressed this topic specifically in the context of day treatment for PD. Thus we do not yet know which patients are most responsive to this form of treatment.
Findings from the few relevant studies suggest that variables such as age, marital status, symptom level, psychological mindedness, and maturity of object relations are predictive of outcome in day treatment. 8 None of these studies investigated predictors of day treatment outcome for a PD sample exclusively. Another difficulty is that identified predictors have been associated with various types of outcomes, such as symptom status, interpersonal distress, or social functioning. Studies rarely define response to treatment more globally, such as improvement on multiple outcome measures. Nonetheless, a more global or comprehensive perspective of response to treatment is what clinicians tend to argue as most relevant to their practice. [9] [10] [11] Studies that attempt to produce information concerning the prediction of more global response to day treatment for PD may be more appealing and useful to clinicians.
Our study aimed to identify predictors of response to day treatment for PD, with response defined comprehensively as reflecting change on multiple outcome measures. Several baseline patient characteristics were considered as potential predictors. These included sociodemographic, diagnostic, severity of PD, and personality characteristics.
Method

Participants
Study participants were consecutively admitted patients to the Psychiatric Day Treatment Program of the University of Alberta Hospital in Edmonton who met inclusion criteria for the program and did not meet exclusion criteria. The primary inclusion criterion for the program was the presence of a PD (that is, the participant met the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, criteria for at least one Axis II PD). Axis II diagnoses were made following a structured clinical interview. 12 To be included in the program, participants also had to be aged at least 18 years and not currently engaged in employed activity or academic study. 
Predictor Variables and Outcome Measures
A wide-ranging set of pretreatment variables representing sociodemographic, diagnostic, severity of PD, and personality characteristics were assessed and considered as potential predictors. Sociodemographic information was collected by the intake therapist. Diagnostic information was derived from the standardized diagnostic assessment 12 that was conducted by an independent assessor. Severity of PD was assessed via the Wisconsin Personality Inventory 14 -a selfreport questionnaire with an interpersonal perspective of PDs. It measures the severity of symptoms and maladaptive behaviours associated with each PD. Personality characteristics that were assessed included quality of object relations, psychological mindedness, attachment style, coping style, and social anxiety. The Quality of Object Relations Scale, 15 a semi-structured interview measure, was used to assess the patient's lifelong pattern of relationships. An overall score on a dimension, ranging from primitive to mature, is derived. Rater reliability (based on 12 patients and 5 raters) was an ICC (2,1) of 0.68. The Psychological Mindedness Assessment Procedure, 16 also a structured interview measure, was used to assess the patient's ability to understand people and their problems in psychological terms. Rater reliability (based on 8 patients and 5 raters) was an ICC (2,1) of 0.91. Attachment style was assessed by the Experiences in Close Relationships Scale, 17 a 36-item self-report measure. The scale provides scores for 2 attachment dimensions: avoidance of intimacy and anxiety about abandonment. The CISS, 18 a 48-item self-report inventory, was used to measure task, avoidance, and emotionoriented coping styles. Social anxiety was assessed using the Social Avoidance and Distress Scale, 19 a 28-item true or false measure.
Various instruments were used at pre-and post-therapy to assess response to treatment. Psychiatric symptoms and functioning were measured with the BSI (GSI score), 20 the SAS (global functioning score), 21 the Inventory of Interpersonal Problems (overall score), 22 and the Quality of Life Inventory (overall score), 23 all of which are self-report measures. The OBI 24 is a structured interview that assesses health and social service contact, as well as dysfunctional behaviours that are often associated with severe PD. Rater reliability (based on 10 patients and 5 raters) was an ICC (2,1) of 0.69 for the Service Use Subscale and an ICC (2,1) of 0.77 for the Dysfunctional Behaviours Subscale. Rater reliability for interview-based measures was assessed using audio recordings of randomly selected samples of interviews, which were rated independently by each of the trained assessors.
Definition of Response and Statistical Analyses
Identification of predictors of response to day treatment required an a priori definition of response. The process of determining overall response to treatment involved several steps. First, we selected 5 scales on which to base the determination of overall response: the SAS, the BSI, the Inventory of Interpersonal Problems, the Quality of Life Inventory, and the OBI-Dysfunctional Behaviours. Then, the change score from baseline to 18 weeks was calculated for each scale. Using these results, the MCID for each measure was used to classify each of the outcome scores into 1 of 3 categories: better, the same, or worse. Based on 2 previous papers, we assumed the MCID for each outcome measure was one-half of the standard deviation of the mean baseline score. 25, 26 Thus better was defined as a standard deviation of 0.5 or more improvement in the score from baseline to 18 weeks, the same was within a 0.5 standard deviation of the baseline score, and worse was an SD of 0.5 or more change in the direction of deterioration. Lastly, participants' overall response to treatment was classified as better, the same, or worse based on having at least 3 outcomes with the same categorical change. In an instance where a patient did not have at least 3 out of 5 outcomes in the same category, a patient was assigned a missing value. Overall response to treatment served as the criterion variable for predictor analyses.
Paired t tests were used to assess change from baseline to 18 weeks (end of treatment). Change on each outcome measure was evaluated with 2 distribution-based approaches: effect size and standardized response mean. The effect size 27, 28 was defined as:
where X 1 is the mean score at 18 weeks of program completion, X 2 is the mean score at baseline, and SD 1 is the standard deviation of the mean baseline scores. An effect size of 1 indicates a mean change in magnitude equivalent to 1 standard deviation. Cohen's 29 criteria were adopted, where absolute values of effect sizes can be categorized as small (<0.5), medium (0.5-0.8), or large (>0.8).
The standardized response mean 27 was defined as:
where X 1 is the mean score at 18 weeks of program completion; X 2 is the mean score at baseline; SD (X 1 -X 2 ) is the standard deviation of the mean change between baseline and 18 weeks. Cohen's 29 criteria were again adopted, which are interpreted as for the effect size. To estimate the empirical 95% confidence intervals of each effect size and standardized response mean, bootstrap sampling with 1000 simulations was performed.
Multivariate polychotomous logistic modelling was used to identify predictors of overall response. The model was described using odds ratios with 95% confidence intervals, and P levels were based on the Wald test. All categorical variables were dummy-coded for inclusion in a regression analysis. To facilitate the identification of potential predictors for inclusion in the final multivariable model, univariate analyses were conducted for each potential predictor. From the univariate analyses, predictors with associations of a P level of less than 0.20 were selected for inclusion in the multivariate model. Then, a backward stepwise approach was used to develop the final multivariate model. Only variables with a P level of less (26) 16 (19) a All changes from baseline to 18 weeks of program completion were statistically significant (P < 0.001)
Note that lower value is better with the exception of the Quality of Life Inventory total score. ES = effect size; SRM = standardized response mean than 0.10 were retained. Given the polychotomous outcome, the Score test was used to test the proportional odds assumption. 30 The -2 log likelihood change in deviance was used to assess the model fit. Analyses were performed using SAS, Version 9.1 (SAS Institute, Cary, NC).
Results
Participant Characteristics
Among the 197 patients who entered the study, 125 completed treatment. Comparison of patients who completed and those who prematurely terminated treatment on 45 baseline variables revealed few (only 4) significant differences. 31 Assessment of outcomes for patients who terminated treatment prematurely was not possible. Thus the remaining 125 patients (82 female, 43 male) who completed treatment were included in the final analysis. The most prevalent PD diagnoses among the patients who completed treatment were avoidant (50%), borderline (48%), and obsessive-compulsive (34%). The mean age of patients on enrolment was 37.1 years (SD 11.0). Ethnicity was distributed as follows: 111 (89%) patients were Caucasian, and 14 (11%) were Asian, East Indian, First Nations, or Hispanic.
Other characteristics of the sample and univariate analyses are shown in Table 1 .
Summary of Outcomes
Paired t tests revealed statistically significant differences between the means at baseline and at 18 weeks for each of the 5 outcomes (Table 2 ). Table 2 also shows moderateto-large effect size and standardized response mean values across outcomes. According to our definition for response to treatment, as outlined above, 69% of patients improved, 25% stayed the same, and 6% deteriorated. Table 3 shows the results of the multivariate polychotomous logistic model. Five variables satisfied the retention criterion (P < 0.10) for remaining in the multivariate model as predictors of response to day treatment for PD. Among the retained variables, 4 met the conventional criterion for statistical significance (P < 0.05). Note that the multivariate model considered the effect of each retained variable after controlling for the effects of all other variables in the model. The odds ratios for these variables not changing appreciably from the univariate model suggests there is limited confounding between these variables and they are measuring unique patient characteristics.
Predictor Analysis
The findings suggest increased odds of being classified as better, with greater severity of baseline psychiatric symptoms, higher level of psychological mindedness, and greater propensity for avoidance style coping; and decreased odds of being classified as better, with higher levels of health and social service use and presence of an SUD. The result of the Score test evaluating the proportional odds assumption (P = 0.53) suggests that this assumption holds, and thus only one model is required (note that only when the P level of the Score test is not statistically significant does the assumption of proportional odds hold).
Discussion
Our study found that day treatment for patients with PDs can be reasonably beneficial. More than two-thirds of patients who completed treatment satisfied our conservative criterion for successful response (that is, improving on at least 3 outcome measures). Among the variables that were predictive of good response to day treatment was psychological mindedness. This finding is consistent with those of other studies. 32, 33 From a psychodynamic perspective, psychological mindedness refers to the ability to identify components of intrapsychic conflict and relate them to a person's problems. 16 It represents a skill that is relevant to performing work in dynamically oriented treatment. In a previous study 34 of day treatment, psychological mindedness was found to be positively associated with work in therapy, which was subsequently found to be related to treatment outcome. Valbak 35 referred to psychological mindedness as one of the primary patient characteristics to consider when assessing a patient's suitability for dynamically oriented psychotherapy.
Also predictive of favourable response was avoidance-oriented coping, which refers to a dispositional tendency to engage in activities and cognitive strategies aimed at avoiding stressful situations. 18 This is an intriguing finding, as one might expect that avoidance coping would compel a patient to disengage from treatment or refuse to explore one's problems in therapy. It may be useful to consider Endler and Parker's 18 conceptualization of avoidance coping to make sense of our finding. They suggest that avoidance coping can occur by distracting oneself with other situations or tasks, or by social diversion. Studies [36] [37] [38] [39] have found that distraction is associated with negative health indicators (for example, neuroticism, anxiety, and somatic complaints), but that social diversion is associated with positive health indicators (for example, extraversion, social adaptability, and optimism). [36] [37] [38] [39] This has led some authors to suggest that social diversion is a distinct form of coping called social coping. 39 Post-hoc analysis using the distraction and social diversion subscores of the CISS Avoidance Coping Scale in place of the total score of the Avoidance Coping Scale in our multivariate model revealed that social diversion emerged as a significant predictor of response. Patients who tended to endorse social diversion as a coping strategy were more likely to be classified as better. Distraction was not significantly related to response. This suggests that patients who have a tendency to use social coping strategies may be better able to make use of the therapeutic factors of the social microcosm that is present within group-oriented treatment. 40 Given the novelty of this finding, more work will be required to clarify the mechanisms through which different coping strategies affect treatment outcome.
We also found that higher baseline levels of symptomatic distress were predictive of favourable response, which is consistent with previous studies. 41 It is unclear why high distress would positively influence treatment outcome, although some have suggested that it may motivate patients to work harder in therapy. 42 We believe it may reflect the law of initial value, or regression to the mean, in that there is a greater likelihood of improvement when baseline levels of distress are high. 43 However, the importance of this finding is in showing that highly distressed patients did not deteriorate in day treatment, but in fact experienced considerable success.
While most patients who completed treatment achieved a successful response, one-quarter of patients experienced minimal change, and a small minority (6%) actually deteriorated. Some factors appeared to work against success in day treatment. The most significant was the presence of an SUD, which is also consistent with previous studies. 44, 45 Some authors have speculated that certain aspects of treatment may be distressing to some patients and incite increased substance use to cope with this distress. 46 For example, substance use is found to be high among patients who are socially anxious. 46 The intense social situation of group-oriented day treatment may be overwhelming for these patients, who then increase their substance use as a way to manage their increased distress.
Others have found that patients with a history of substance use have poorer adjustment to the therapeutic milieu of day treatment. 47 Finally, our results indicated that high health and social service use significantly impeded patients' chances of benefiting from day treatment. High service use has been found to be associated with poorer cognitive functioning, 48 perhaps reflecting underdevelopment of the verbal and cognitive skills necessary for comprehension and execution of work within the treatment environment. Others have found that preoccupied attachment was related to hospital use. 49 Increased service use could be associated with an intense wish for protection and nurturing, leading to increased proximity-seeking with health care providers. However, these people are quick to become frustrated when their need for closeness is not met and are prone to act out their frustration. Although our study included a measure of attachment (which was not associated with the outcome), the measure did not assess preoccupied attachment.
Our study possessed certain strengths and limitations. Regarding strengths, we used a reasonably large clinical sample of patients with PD, considered a wide variety of potential predictors of response, and used a thorough, systematic approach to identify predictors using a comprehensive multivariate model. In addition, we imposed a conservative and comprehensive definition of response, which lends confidence to our findings. Concerning limitations, numerous patients who began treatment failed to provide posttherapy data. While these patients did not differ significantly from those with complete data on several baseline characteristics, it is still possible that the nonproviders represented a less successful cohort. In addition, although a comprehensive set of possible predictors of response was considered, it is likely that there are relevant predictors that we did not measure and include in the analysis. Finally, absence of a control group limited our ability to make conclusions about treatment efficacy.
Conclusion
Notwithstanding these limitations, the findings suggest that patients' response to day treatment appears to be enhanced by high psychological mindedness and use of socially oriented avoidance coping strategies. Patients with high baseline symptom severity had a high probability of favourable response, thus pointing to the suitability of day treatment for such patients. Finally, success in treatment appeared to be more limited for patients presenting with SUDs and a history of high health and social service use. Day treatment for patients with PD is a viable treatment option. 50, 51 Future work to identify factors that contribute to remaining and benefiting from this type of treatment will help to make it more efficient and effective.
